Type 1 diabetes

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes

N Engl J MedPublished Phase 1-2 study

Authors' conclusion

The results of this small, short-term study involving persons with type 1 diabetes support the hypothesis that zimislecel can restore physiologic islet function, warranting further clinical investigation.

Study context

Population
Persons with T1D; all received glucocorticoid-free immunosuppressive therapy≥12 months follow-up
Participants
14 persons
Comparison
Zimislecel half dose and full dose
  • Part An = 2
  • Parts B and Cn = 12
Outcome
Part C: freedom from severe hypoglycemic events (days 90–365) with HbA1c <7% or decrease ≥1 percentage point from baseline at ≥1 time point between days 180 and 365; part A: safety
Follow-up
Days 90 through 365
Methodological detailsinterim analyses, not prespecified
  • Interim analyses
  • Not prespecified

Main finding

As reported in the abstract

Free of severe hypoglycemic events and HbA1c <7%

Parts B and C

12

events

All 12 participants in parts B and C met the primary end point
12 of 12

Secondary outcomes

Insulin independence (no exogenous insulin) · day 365

Ten of the 12 participants in parts B and C had insulin independence and were not using exogenous insulin
10 of 12 (83%)
  • Interim analysis, not prespecified

Time in target glucose range (70 to 180 mg/dL)

All 12 participants in parts B and C spent >70% of time in target range

Engraftment and islet function (C-peptide detection during mixed-meal tolerance test)

C-peptide undetectable at baseline in all participants
14
All participants had engraftment and islet function, as evidenced by C-peptide detection

Safety

Neutropenia, most common serious adverse event
3 participants
Deaths (1 cryptococcal meningitis; 1 severe dementia with agitation from progression of preexisting neurocognitive impairment)
2

Original publication

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes. N Engl J Med. Published 20 June 2025. doi:10.1056/nejmoa2506549

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.